Intact Vascular Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 62
Employees
  • Latest Deal Type
  • Debt Repay.
  • Latest Deal Amount
  • $15M
Latest Deal Amount
  • Investors
  • 5

Intact Vascular General Information

Description

Developer of minimally invasive peripheral vascular products intended to substantially improve clinical outcomes and quality of life. The company is committed to develop safe, efficacious, and easy-to-use products for patients with vascular disease, thus providing physicians with a new treatment option for peripheral artery diseases.

Contact Information

Formerly Known As
Tackit Vascular
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Decision/Risk Analysis
Primary Office
  • 1285 Drummers Lane
  • Suite 200
  • Wayne, PA 19087
  • United States
+1 (484) 000-0000

Intact Vascular Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Intact Vascular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Debt Repayment 04-Sep-2020 $15M Completed Generating Revenue
8. Merger/Acquisition 27-Aug-2020 00000 00000 00000 Announced Generating Revenue
7. Debt - General 09-Jul-2020 0000 00000 Completed Generating Revenue
6. Later Stage VC 05-May-2020 000.00 00000 Completed Generating Revenue
5. Later Stage VC (Series C) 24-May-2019 0000 00000 00000 Completed Generating Revenue
4. Later Stage VC (Series C) 16-Apr-2018 0000 000.00 00000 Completed Generating Revenue
3. Later Stage VC (Series B) 03-Jan-2017 0000 000.00 0000 Completed Generating Revenue
2. Early Stage VC (Series A2) 20-Dec-2013 $4.69M $20.2M 000.00 Completed Startup
1. Early Stage VC (Series A2) 30-Aug-2012 $15.5M $15.5M 000.00 Completed Startup
To view Intact Vascular’s complete valuation and funding history, request access »

Intact Vascular Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B1 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series A2 18,171,588 $0.001000 8% $0.92 $0.92 1x $0.92 11.9%
Series A1 4,050,000 $0.001000 8% $0.25
To view Intact Vascular’s complete cap table history, request access »

Intact Vascular Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of minimally invasive peripheral vascular products intended to substantially improve clinical outcomes and qua
Therapeutic Devices
Wayne, PA
62 As of 2020
00000
000000000 00

00 00000

velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, s
00000000 0000000
Milpitas, CA
00 As of 0000
00000
00000000000 00000

000000 0

bore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi
00000000 0000000
Wayne, PA
000.00
00.00 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Intact Vascular Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PQ Bypass Venture Capital-Backed Milpitas, CA 00 00000 00000000000 00000
000000 0000000 Venture Capital-Backed Wayne, PA 000.00 00000000000 000.00
00000000 000000000 Venture Capital-Backed Emeryville, CA 00 000.00 000000000 - 000.00
0000 000000 0000 Venture Capital-Backed Plymouth, MN 00 000.00 0000000000 0 000.00
0000000000000 Corporation New York, NY 000 000000 - 000
You’re viewing 5 of 15 competitors. Get the full list »

Intact Vascular Executive Team (15)

Name Title Board Seat Contact Info
Jim Harrison Director, Implant Research & Development
Marc Penna Vice President of Clinical Affairs
Howard Rosen Vice President of Marketing & Business Development
Joseph Griffin III Vice President of Regulatory Affairs & Quality Assurance
Michael Longo Vice President, Research & Development
You’re viewing 5 of 15 executive team members. Get the full list »

Intact Vascular Board Members (11)

Name Representing Role Since
Bruce Robertson Ph.D H.I.G. BioHealth Partners Board Member 000 0000
Bruce Shook Self Chief Executive Officer, President & Board Member 000 0000
Dennis Wahr MD Self Chairman 000 0000
Douglas Evans Self Board Member 000 0000
Joshua Makower MD New Enterprise Associates Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Intact Vascular Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Intact Vascular Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Vensana Capital Venture Capital Minority 000 0000 000000 0
New Enterprise Associates Venture Capital Minority 000 0000 000000 0
H.I.G. BioHealth Partners Venture Capital Minority 000 0000 000000 0
Quaker Partners Venture Capital Minority 000 0000 000000 0
Philips Corporation Majority 000 0000 000000 0
To view Intact Vascular’s complete investors history, request access »